Table 1.
Demographics, clinical characteristics and ultrasound severity classification of patients included.
| Demographics and Clinical Characteristics |
Number of Patients (n = 96) |
|---|---|
| Gender (n (%)) | |
| Male | 53 (55.2%) |
| Female | 43 (44.8%) |
| Age (mean ± SD); (n (%)) | |
| Mean age (years) | 55.79 ± 13.3 |
| 20–35 years | 8 (8.3%) |
| 35–50 years | 21 (21.8%) |
| 50–65 years | 45 (46.8%) |
| 65–80 years | 19 (19.7%) |
| ≥80 years | 3 (3.1%) |
| Medical History (n (%)) | |
| Hypertension | 29 (30.2%) |
| Diabetes mellitus | 10 (10.4%) |
| Overweight or obesity | 54 (56.2%) |
| Chronic heart disease | 8 (8.3%) |
| COPD/asthma | 16 (16.6%) |
| Therapy received during hospitalization (n (%)) | |
| Corticosteroids | 71 (73.9%) |
| Antibiotics | 65 (67.7%) |
| Tocilizumab (anti-interleukin 6) | 34 (35.4%) |
| Anakinra (anti-interleukin 1) | 3 (3.1%) |
| Classification according to Severity (n (%)) | |
| No ARDS (PaFi ≥ 300 mmHg) | 22 (22.9%) |
| Mild ARDS (PaFi 200–299 mmHg) | 11 (11.4%) |
| Moderate ARDS (PaFi 100–199 mmHg) | 37 (38.5%) |
| Severe ARDS (PaFi < 100 mmHg) | 26 (27%) |
| Complications during hospitalization and follow-up | |
| NIMV | 15 (15.6%) |
| PE | 14 (14.6%) |
| Heart failure | 4 (4.1%) |
| IMV | 6 (6.2%) |
ARDS: Acute respiratory distress syndrome; COPD: Chronic obstructive pulmonary disease; IMV: Invasive mechanical ventilation; NIMV: Non-invasive mechanical ventilation; PaFi: PaO2/FiO2; PE: Pulmonary embolism.